nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ALB—rheumatoid arthritis	0.236	1	CbGaD
Canagliflozin—ALB—Auranofin—rheumatoid arthritis	0.106	0.18	CbGbCtD
Canagliflozin—ABCC2—Sulfasalazine—rheumatoid arthritis	0.0674	0.115	CbGbCtD
Canagliflozin—ABCC2—Cyclosporine—rheumatoid arthritis	0.0511	0.087	CbGbCtD
Canagliflozin—ABCC2—Dexamethasone—rheumatoid arthritis	0.0337	0.0573	CbGbCtD
Canagliflozin—ALB—Prednisone—rheumatoid arthritis	0.0336	0.0572	CbGbCtD
Canagliflozin—ABCB1—Methylprednisolone—rheumatoid arthritis	0.029	0.0494	CbGbCtD
Canagliflozin—ABCC2—Methotrexate—rheumatoid arthritis	0.027	0.046	CbGbCtD
Canagliflozin—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0236	0.0401	CbGbCtD
Canagliflozin—ABCB1—Betamethasone—rheumatoid arthritis	0.0189	0.0321	CbGbCtD
Canagliflozin—ABCB1—Prednisolone—rheumatoid arthritis	0.0186	0.0317	CbGbCtD
Canagliflozin—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0176	0.03	CbGbCtD
Canagliflozin—ABCB1—Prednisone—rheumatoid arthritis	0.0176	0.0299	CbGbCtD
Canagliflozin—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0174	0.0296	CbGbCtD
Canagliflozin—ALB—Methotrexate—rheumatoid arthritis	0.0169	0.0287	CbGbCtD
Canagliflozin—ABCB1—Cyclosporine—rheumatoid arthritis	0.0167	0.0284	CbGbCtD
Canagliflozin—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0132	0.0224	CbGbCtD
Canagliflozin—CYP3A4—Betamethasone—rheumatoid arthritis	0.0113	0.0192	CbGbCtD
Canagliflozin—CYP3A4—Prednisolone—rheumatoid arthritis	0.0112	0.019	CbGbCtD
Canagliflozin—ABCB1—Dexamethasone—rheumatoid arthritis	0.011	0.0187	CbGbCtD
Canagliflozin—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0106	0.018	CbGbCtD
Canagliflozin—CYP3A4—Prednisone—rheumatoid arthritis	0.0105	0.0179	CbGbCtD
Canagliflozin—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00998	0.017	CbGbCtD
Canagliflozin—ABCB1—Methotrexate—rheumatoid arthritis	0.00882	0.015	CbGbCtD
Canagliflozin—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00657	0.0112	CbGbCtD
Canagliflozin—Diabetes mellitus—Betamethasone—rheumatoid arthritis	0.000418	0.00356	CcSEcCtD
Canagliflozin—Pancreatitis—Cyclosporine—rheumatoid arthritis	0.000406	0.00346	CcSEcCtD
Canagliflozin—Nausea—Auranofin—rheumatoid arthritis	0.000399	0.0034	CcSEcCtD
Canagliflozin—Rash—Penicillamine—rheumatoid arthritis	0.000391	0.00333	CcSEcCtD
Canagliflozin—Dermatitis—Penicillamine—rheumatoid arthritis	0.000391	0.00333	CcSEcCtD
Canagliflozin—Pollakiuria—Cyclosporine—rheumatoid arthritis	0.000383	0.00326	CcSEcCtD
Canagliflozin—Malnutrition—Leflunomide—rheumatoid arthritis	0.000374	0.00318	CcSEcCtD
Canagliflozin—Pancreatitis—Prednisolone—rheumatoid arthritis	0.000369	0.00314	CcSEcCtD
Canagliflozin—Nausea—Penicillamine—rheumatoid arthritis	0.000369	0.00314	CcSEcCtD
Canagliflozin—Diabetes mellitus—Prednisone—rheumatoid arthritis	0.000364	0.0031	CcSEcCtD
Canagliflozin—Breast disorder—Methylprednisolone—rheumatoid arthritis	0.000362	0.00308	CcSEcCtD
Canagliflozin—Pancreatitis—Hydrocortisone—rheumatoid arthritis	0.000361	0.00307	CcSEcCtD
Canagliflozin—Urinary tract infection—Cyclosporine—rheumatoid arthritis	0.000359	0.00305	CcSEcCtD
Canagliflozin—Cystitis noninfective—Methotrexate—rheumatoid arthritis	0.000356	0.00303	CcSEcCtD
Canagliflozin—Cystitis—Methotrexate—rheumatoid arthritis	0.000352	0.003	CcSEcCtD
Canagliflozin—Vaginal infection—Methotrexate—rheumatoid arthritis	0.000344	0.00293	CcSEcCtD
Canagliflozin—Angioedema—Leflunomide—rheumatoid arthritis	0.000342	0.00291	CcSEcCtD
Canagliflozin—Pancreatitis—Triamcinolone—rheumatoid arthritis	0.00034	0.00289	CcSEcCtD
Canagliflozin—Pancreatitis—Methylprednisolone—rheumatoid arthritis	0.000339	0.00289	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.000335	0.00285	CcSEcCtD
Canagliflozin—Urine output increased—Methotrexate—rheumatoid arthritis	0.00033	0.00281	CcSEcCtD
Canagliflozin—Bladder pain—Methotrexate—rheumatoid arthritis	0.00033	0.00281	CcSEcCtD
Canagliflozin—Urinary tract disorder—Cyclosporine—rheumatoid arthritis	0.000327	0.00279	CcSEcCtD
Canagliflozin—Urethral disorder—Cyclosporine—rheumatoid arthritis	0.000325	0.00277	CcSEcCtD
Canagliflozin—Infection—Azathioprine—rheumatoid arthritis	0.000321	0.00273	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000316	0.00269	CcSEcCtD
Canagliflozin—Skin disorder—Azathioprine—rheumatoid arthritis	0.000314	0.00267	CcSEcCtD
Canagliflozin—Dry mouth—Leflunomide—rheumatoid arthritis	0.000311	0.00265	CcSEcCtD
Canagliflozin—Diabetes mellitus—Methotrexate—rheumatoid arthritis	0.000304	0.00259	CcSEcCtD
Canagliflozin—Infection—Leflunomide—rheumatoid arthritis	0.000303	0.00258	CcSEcCtD
Canagliflozin—Hypotension—Azathioprine—rheumatoid arthritis	0.000302	0.00257	CcSEcCtD
Canagliflozin—Photosensitivity—Methotrexate—rheumatoid arthritis	0.000302	0.00257	CcSEcCtD
Canagliflozin—Polyuria—Methotrexate—rheumatoid arthritis	0.000302	0.00257	CcSEcCtD
Canagliflozin—Angiopathy—Cyclosporine—rheumatoid arthritis	0.000301	0.00256	CcSEcCtD
Canagliflozin—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000299	0.00255	CcSEcCtD
Canagliflozin—Skin disorder—Leflunomide—rheumatoid arthritis	0.000296	0.00252	CcSEcCtD
Canagliflozin—Malnutrition—Cyclosporine—rheumatoid arthritis	0.000289	0.00246	CcSEcCtD
Canagliflozin—Renal failure acute—Methotrexate—rheumatoid arthritis	0.000287	0.00244	CcSEcCtD
Canagliflozin—Hypotension—Leflunomide—rheumatoid arthritis	0.000285	0.00243	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000279	0.00237	CcSEcCtD
Canagliflozin—Pancreatitis—Prednisone—rheumatoid arthritis	0.000268	0.00229	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000264	0.00225	CcSEcCtD
Canagliflozin—Angioedema—Cyclosporine—rheumatoid arthritis	0.000264	0.00224	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000263	0.00224	CcSEcCtD
Canagliflozin—Fatigue—Leflunomide—rheumatoid arthritis	0.000263	0.00224	CcSEcCtD
Canagliflozin—Erythema—Prednisolone—rheumatoid arthritis	0.000263	0.00223	CcSEcCtD
Canagliflozin—Constipation—Leflunomide—rheumatoid arthritis	0.000261	0.00222	CcSEcCtD
Canagliflozin—Erythema—Hydrocortisone—rheumatoid arthritis	0.000256	0.00218	CcSEcCtD
Canagliflozin—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.000256	0.00218	CcSEcCtD
Canagliflozin—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000255	0.00217	CcSEcCtD
Canagliflozin—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000251	0.00214	CcSEcCtD
Canagliflozin—Convulsion—Cyclosporine—rheumatoid arthritis	0.00025	0.00213	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.00025	0.00212	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000244	0.00208	CcSEcCtD
Canagliflozin—Urticaria—Leflunomide—rheumatoid arthritis	0.000242	0.00206	CcSEcCtD
Canagliflozin—Erythema—Triamcinolone—rheumatoid arthritis	0.000241	0.00206	CcSEcCtD
Canagliflozin—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000241	0.00205	CcSEcCtD
Canagliflozin—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000241	0.00205	CcSEcCtD
Canagliflozin—Erythema—Methylprednisolone—rheumatoid arthritis	0.000241	0.00205	CcSEcCtD
Canagliflozin—Dry mouth—Cyclosporine—rheumatoid arthritis	0.00024	0.00204	CcSEcCtD
Canagliflozin—Angioedema—Prednisolone—rheumatoid arthritis	0.00024	0.00204	CcSEcCtD
Canagliflozin—Breast disorder—Methotrexate—rheumatoid arthritis	0.000239	0.00204	CcSEcCtD
Canagliflozin—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000238	0.00203	CcSEcCtD
Canagliflozin—Syncope—Prednisolone—rheumatoid arthritis	0.000235	0.002	CcSEcCtD
Canagliflozin—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000234	0.00199	CcSEcCtD
Canagliflozin—Infection—Cyclosporine—rheumatoid arthritis	0.000234	0.00199	CcSEcCtD
Canagliflozin—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000231	0.00197	CcSEcCtD
Canagliflozin—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000231	0.00196	CcSEcCtD
Canagliflozin—Syncope—Hydrocortisone—rheumatoid arthritis	0.00023	0.00196	CcSEcCtD
Canagliflozin—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000229	0.00195	CcSEcCtD
Canagliflozin—Angiopathy—Betamethasone—rheumatoid arthritis	0.000228	0.00194	CcSEcCtD
Canagliflozin—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000228	0.00194	CcSEcCtD
Canagliflozin—Convulsion—Prednisolone—rheumatoid arthritis	0.000227	0.00194	CcSEcCtD
Canagliflozin—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.000225	0.00192	CcSEcCtD
Canagliflozin—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000225	0.00191	CcSEcCtD
Canagliflozin—Pancreatitis—Methotrexate—rheumatoid arthritis	0.000224	0.00191	CcSEcCtD
Canagliflozin—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000222	0.00189	CcSEcCtD
Canagliflozin—Angioedema—Triamcinolone—rheumatoid arthritis	0.000221	0.00188	CcSEcCtD
Canagliflozin—Angioedema—Methylprednisolone—rheumatoid arthritis	0.00022	0.00187	CcSEcCtD
Canagliflozin—Erythema—Dexamethasone—rheumatoid arthritis	0.000219	0.00186	CcSEcCtD
Canagliflozin—Erythema—Betamethasone—rheumatoid arthritis	0.000219	0.00186	CcSEcCtD
Canagliflozin—Asthenia—Leflunomide—rheumatoid arthritis	0.000219	0.00186	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000217	0.00185	CcSEcCtD
Canagliflozin—Syncope—Triamcinolone—rheumatoid arthritis	0.000217	0.00184	CcSEcCtD
Canagliflozin—Syncope—Methylprednisolone—rheumatoid arthritis	0.000216	0.00184	CcSEcCtD
Canagliflozin—Pruritus—Leflunomide—rheumatoid arthritis	0.000216	0.00184	CcSEcCtD
Canagliflozin—Dizziness—Azathioprine—rheumatoid arthritis	0.000214	0.00182	CcSEcCtD
Canagliflozin—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000212	0.00181	CcSEcCtD
Canagliflozin—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000212	0.0018	CcSEcCtD
Canagliflozin—Shock—Prednisolone—rheumatoid arthritis	0.000211	0.00179	CcSEcCtD
Canagliflozin—Convulsion—Triamcinolone—rheumatoid arthritis	0.000209	0.00178	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Methotrexate—rheumatoid arthritis	0.000209	0.00178	CcSEcCtD
Canagliflozin—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000209	0.00178	CcSEcCtD
Canagliflozin—Infection—Hydrocortisone—rheumatoid arthritis	0.000208	0.00177	CcSEcCtD
Canagliflozin—Shock—Hydrocortisone—rheumatoid arthritis	0.000206	0.00175	CcSEcCtD
Canagliflozin—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000205	0.00175	CcSEcCtD
Canagliflozin—Rash—Azathioprine—rheumatoid arthritis	0.000204	0.00173	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000204	0.00173	CcSEcCtD
Canagliflozin—Dermatitis—Azathioprine—rheumatoid arthritis	0.000204	0.00173	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000203	0.00173	CcSEcCtD
Canagliflozin—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000203	0.00173	CcSEcCtD
Canagliflozin—Fatigue—Cyclosporine—rheumatoid arthritis	0.000203	0.00173	CcSEcCtD
Canagliflozin—Dizziness—Leflunomide—rheumatoid arthritis	0.000202	0.00172	CcSEcCtD
Canagliflozin—Constipation—Cyclosporine—rheumatoid arthritis	0.000201	0.00171	CcSEcCtD
Canagliflozin—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000201	0.00171	CcSEcCtD
Canagliflozin—Angioedema—Betamethasone—rheumatoid arthritis	0.0002	0.0017	CcSEcCtD
Canagliflozin—Angioedema—Dexamethasone—rheumatoid arthritis	0.0002	0.0017	CcSEcCtD
Canagliflozin—Angiopathy—Prednisone—rheumatoid arthritis	0.000199	0.00169	CcSEcCtD
Canagliflozin—Syncope—Betamethasone—rheumatoid arthritis	0.000196	0.00167	CcSEcCtD
Canagliflozin—Syncope—Dexamethasone—rheumatoid arthritis	0.000196	0.00167	CcSEcCtD
Canagliflozin—Infection—Triamcinolone—rheumatoid arthritis	0.000196	0.00167	CcSEcCtD
Canagliflozin—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000196	0.00166	CcSEcCtD
Canagliflozin—Infection—Methylprednisolone—rheumatoid arthritis	0.000195	0.00166	CcSEcCtD
Canagliflozin—Shock—Triamcinolone—rheumatoid arthritis	0.000194	0.00165	CcSEcCtD
Canagliflozin—Shock—Methylprednisolone—rheumatoid arthritis	0.000193	0.00165	CcSEcCtD
Canagliflozin—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000193	0.00164	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000193	0.00164	CcSEcCtD
Canagliflozin—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000193	0.00164	CcSEcCtD
Canagliflozin—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000193	0.00164	CcSEcCtD
Canagliflozin—Rash—Leflunomide—rheumatoid arthritis	0.000192	0.00164	CcSEcCtD
Canagliflozin—Dermatitis—Leflunomide—rheumatoid arthritis	0.000192	0.00164	CcSEcCtD
Canagliflozin—Nausea—Azathioprine—rheumatoid arthritis	0.000192	0.00163	CcSEcCtD
Canagliflozin—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000191	0.00163	CcSEcCtD
Canagliflozin—Erythema—Prednisone—rheumatoid arthritis	0.000191	0.00162	CcSEcCtD
Canagliflozin—Malnutrition—Prednisone—rheumatoid arthritis	0.000191	0.00162	CcSEcCtD
Canagliflozin—Convulsion—Dexamethasone—rheumatoid arthritis	0.00019	0.00162	CcSEcCtD
Canagliflozin—Convulsion—Betamethasone—rheumatoid arthritis	0.00019	0.00162	CcSEcCtD
Canagliflozin—Urticaria—Cyclosporine—rheumatoid arthritis	0.000187	0.00159	CcSEcCtD
Canagliflozin—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000186	0.00158	CcSEcCtD
Canagliflozin—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000184	0.00156	CcSEcCtD
Canagliflozin—Nausea—Leflunomide—rheumatoid arthritis	0.000181	0.00154	CcSEcCtD
Canagliflozin—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000181	0.00154	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000181	0.00154	CcSEcCtD
Canagliflozin—Fatigue—Hydrocortisone—rheumatoid arthritis	0.00018	0.00154	CcSEcCtD
Canagliflozin—Urethral disorder—Methotrexate—rheumatoid arthritis	0.00018	0.00153	CcSEcCtD
Canagliflozin—Infection—Dexamethasone—rheumatoid arthritis	0.000178	0.00151	CcSEcCtD
Canagliflozin—Infection—Betamethasone—rheumatoid arthritis	0.000178	0.00151	CcSEcCtD
Canagliflozin—Shock—Betamethasone—rheumatoid arthritis	0.000176	0.0015	CcSEcCtD
Canagliflozin—Shock—Dexamethasone—rheumatoid arthritis	0.000176	0.0015	CcSEcCtD
Canagliflozin—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000175	0.00149	CcSEcCtD
Canagliflozin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000175	0.00149	CcSEcCtD
Canagliflozin—Angioedema—Prednisone—rheumatoid arthritis	0.000174	0.00148	CcSEcCtD
Canagliflozin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000174	0.00148	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000171	0.00146	CcSEcCtD
Canagliflozin—Syncope—Prednisone—rheumatoid arthritis	0.000171	0.00146	CcSEcCtD
Canagliflozin—Urticaria—Prednisolone—rheumatoid arthritis	0.00017	0.00145	CcSEcCtD
Canagliflozin—Fatigue—Triamcinolone—rheumatoid arthritis	0.00017	0.00145	CcSEcCtD
Canagliflozin—Fatigue—Methylprednisolone—rheumatoid arthritis	0.00017	0.00144	CcSEcCtD
Canagliflozin—Asthenia—Cyclosporine—rheumatoid arthritis	0.000169	0.00144	CcSEcCtD
Canagliflozin—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000168	0.00143	CcSEcCtD
Canagliflozin—Hypotension—Dexamethasone—rheumatoid arthritis	0.000167	0.00142	CcSEcCtD
Canagliflozin—Hypotension—Betamethasone—rheumatoid arthritis	0.000167	0.00142	CcSEcCtD
Canagliflozin—Pruritus—Cyclosporine—rheumatoid arthritis	0.000167	0.00142	CcSEcCtD
Canagliflozin—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000166	0.00142	CcSEcCtD
Canagliflozin—Angiopathy—Methotrexate—rheumatoid arthritis	0.000166	0.00141	CcSEcCtD
Canagliflozin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000165	0.00141	CcSEcCtD
Canagliflozin—Convulsion—Prednisone—rheumatoid arthritis	0.000165	0.00141	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000161	0.00137	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000161	0.00137	CcSEcCtD
Canagliflozin—Erythema—Methotrexate—rheumatoid arthritis	0.000159	0.00136	CcSEcCtD
Canagliflozin—Malnutrition—Methotrexate—rheumatoid arthritis	0.000159	0.00136	CcSEcCtD
Canagliflozin—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000158	0.00134	CcSEcCtD
Canagliflozin—Urticaria—Triamcinolone—rheumatoid arthritis	0.000157	0.00133	CcSEcCtD
Canagliflozin—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000156	0.00133	CcSEcCtD
Canagliflozin—Dizziness—Cyclosporine—rheumatoid arthritis	0.000156	0.00133	CcSEcCtD
Canagliflozin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000155	0.00132	CcSEcCtD
Canagliflozin—Infection—Prednisone—rheumatoid arthritis	0.000155	0.00132	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000154	0.00131	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000154	0.00131	CcSEcCtD
Canagliflozin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000154	0.00131	CcSEcCtD
Canagliflozin—Fatigue—Betamethasone—rheumatoid arthritis	0.000154	0.00131	CcSEcCtD
Canagliflozin—Fatigue—Dexamethasone—rheumatoid arthritis	0.000154	0.00131	CcSEcCtD
Canagliflozin—Shock—Prednisone—rheumatoid arthritis	0.000153	0.0013	CcSEcCtD
Canagliflozin—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000153	0.0013	CcSEcCtD
Canagliflozin—Skin disorder—Prednisone—rheumatoid arthritis	0.000151	0.00129	CcSEcCtD
Canagliflozin—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00015	0.00128	CcSEcCtD
Canagliflozin—Rash—Cyclosporine—rheumatoid arthritis	0.000148	0.00126	CcSEcCtD
Canagliflozin—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000148	0.00126	CcSEcCtD
Canagliflozin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000148	0.00126	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000146	0.00124	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000146	0.00124	CcSEcCtD
Canagliflozin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000145	0.00124	CcSEcCtD
Canagliflozin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000145	0.00123	CcSEcCtD
Canagliflozin—Urticaria—Dexamethasone—rheumatoid arthritis	0.000142	0.00121	CcSEcCtD
Canagliflozin—Urticaria—Betamethasone—rheumatoid arthritis	0.000142	0.00121	CcSEcCtD
Canagliflozin—Dizziness—Prednisolone—rheumatoid arthritis	0.000142	0.00121	CcSEcCtD
Canagliflozin—Asthenia—Triamcinolone—rheumatoid arthritis	0.000141	0.0012	CcSEcCtD
Canagliflozin—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000141	0.0012	CcSEcCtD
Canagliflozin—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000141	0.0012	CcSEcCtD
Canagliflozin—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000141	0.0012	CcSEcCtD
Canagliflozin—Nausea—Cyclosporine—rheumatoid arthritis	0.00014	0.00119	CcSEcCtD
Canagliflozin—Pruritus—Triamcinolone—rheumatoid arthritis	0.000139	0.00119	CcSEcCtD
Canagliflozin—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000139	0.00118	CcSEcCtD
Canagliflozin—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000138	0.00118	CcSEcCtD
Canagliflozin—Convulsion—Methotrexate—rheumatoid arthritis	0.000138	0.00118	CcSEcCtD
Canagliflozin—Rash—Prednisolone—rheumatoid arthritis	0.000135	0.00115	CcSEcCtD
Canagliflozin—Dermatitis—Prednisolone—rheumatoid arthritis	0.000135	0.00115	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000135	0.00115	CcSEcCtD
Canagliflozin—Fatigue—Prednisone—rheumatoid arthritis	0.000134	0.00114	CcSEcCtD
Canagliflozin—Constipation—Prednisone—rheumatoid arthritis	0.000133	0.00113	CcSEcCtD
Canagliflozin—Rash—Hydrocortisone—rheumatoid arthritis	0.000132	0.00112	CcSEcCtD
Canagliflozin—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000132	0.00112	CcSEcCtD
Canagliflozin—Dizziness—Triamcinolone—rheumatoid arthritis	0.00013	0.00111	CcSEcCtD
Canagliflozin—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00013	0.00111	CcSEcCtD
Canagliflozin—Infection—Methotrexate—rheumatoid arthritis	0.000129	0.0011	CcSEcCtD
Canagliflozin—Asthenia—Betamethasone—rheumatoid arthritis	0.000128	0.00109	CcSEcCtD
Canagliflozin—Asthenia—Dexamethasone—rheumatoid arthritis	0.000128	0.00109	CcSEcCtD
Canagliflozin—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000128	0.00109	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000127	0.00108	CcSEcCtD
Canagliflozin—Nausea—Prednisolone—rheumatoid arthritis	0.000127	0.00108	CcSEcCtD
Canagliflozin—Pruritus—Dexamethasone—rheumatoid arthritis	0.000127	0.00108	CcSEcCtD
Canagliflozin—Pruritus—Betamethasone—rheumatoid arthritis	0.000127	0.00108	CcSEcCtD
Canagliflozin—Skin disorder—Methotrexate—rheumatoid arthritis	0.000126	0.00108	CcSEcCtD
Canagliflozin—Nausea—Hydrocortisone—rheumatoid arthritis	0.000124	0.00106	CcSEcCtD
Canagliflozin—Rash—Triamcinolone—rheumatoid arthritis	0.000124	0.00106	CcSEcCtD
Canagliflozin—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000124	0.00106	CcSEcCtD
Canagliflozin—Rash—Methylprednisolone—rheumatoid arthritis	0.000124	0.00106	CcSEcCtD
Canagliflozin—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000124	0.00105	CcSEcCtD
Canagliflozin—Urticaria—Prednisone—rheumatoid arthritis	0.000124	0.00105	CcSEcCtD
Canagliflozin—Abdominal pain—Prednisone—rheumatoid arthritis	0.000123	0.00105	CcSEcCtD
Canagliflozin—Hypotension—Methotrexate—rheumatoid arthritis	0.000122	0.00104	CcSEcCtD
Canagliflozin—Dizziness—Betamethasone—rheumatoid arthritis	0.000118	0.00101	CcSEcCtD
Canagliflozin—Dizziness—Dexamethasone—rheumatoid arthritis	0.000118	0.00101	CcSEcCtD
Canagliflozin—Nausea—Triamcinolone—rheumatoid arthritis	0.000117	0.000996	CcSEcCtD
Canagliflozin—Nausea—Methylprednisolone—rheumatoid arthritis	0.000117	0.000994	CcSEcCtD
Canagliflozin—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000115	0.000976	CcSEcCtD
Canagliflozin—Rash—Betamethasone—rheumatoid arthritis	0.000113	0.00096	CcSEcCtD
Canagliflozin—Rash—Dexamethasone—rheumatoid arthritis	0.000113	0.00096	CcSEcCtD
Canagliflozin—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000113	0.000959	CcSEcCtD
Canagliflozin—Dermatitis—Betamethasone—rheumatoid arthritis	0.000113	0.000959	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000112	0.000956	CcSEcCtD
Canagliflozin—Fatigue—Methotrexate—rheumatoid arthritis	0.000112	0.000955	CcSEcCtD
Canagliflozin—Asthenia—Prednisone—rheumatoid arthritis	0.000112	0.000951	CcSEcCtD
Canagliflozin—Pruritus—Prednisone—rheumatoid arthritis	0.00011	0.000938	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000106	0.000906	CcSEcCtD
Canagliflozin—Nausea—Dexamethasone—rheumatoid arthritis	0.000106	0.000904	CcSEcCtD
Canagliflozin—Nausea—Betamethasone—rheumatoid arthritis	0.000106	0.000904	CcSEcCtD
Canagliflozin—Urticaria—Methotrexate—rheumatoid arthritis	0.000103	0.00088	CcSEcCtD
Canagliflozin—Dizziness—Prednisone—rheumatoid arthritis	0.000103	0.000876	CcSEcCtD
Canagliflozin—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000103	0.000876	CcSEcCtD
Canagliflozin—Rash—Prednisone—rheumatoid arthritis	9.82e-05	0.000836	CcSEcCtD
Canagliflozin—Dermatitis—Prednisone—rheumatoid arthritis	9.81e-05	0.000835	CcSEcCtD
Canagliflozin—Hypersensitivity—Methotrexate—rheumatoid arthritis	9.59e-05	0.000816	CcSEcCtD
Canagliflozin—Asthenia—Methotrexate—rheumatoid arthritis	9.34e-05	0.000795	CcSEcCtD
Canagliflozin—Nausea—Prednisone—rheumatoid arthritis	9.25e-05	0.000787	CcSEcCtD
Canagliflozin—Pruritus—Methotrexate—rheumatoid arthritis	9.21e-05	0.000784	CcSEcCtD
Canagliflozin—Dizziness—Methotrexate—rheumatoid arthritis	8.61e-05	0.000732	CcSEcCtD
Canagliflozin—Rash—Methotrexate—rheumatoid arthritis	8.21e-05	0.000698	CcSEcCtD
Canagliflozin—Dermatitis—Methotrexate—rheumatoid arthritis	8.2e-05	0.000698	CcSEcCtD
Canagliflozin—Nausea—Methotrexate—rheumatoid arthritis	7.73e-05	0.000658	CcSEcCtD
Canagliflozin—SLC5A1—Disease—STAT1—rheumatoid arthritis	7.24e-05	0.00124	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	7.15e-05	0.00122	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—FADS2—rheumatoid arthritis	7.14e-05	0.00122	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALOX5—rheumatoid arthritis	7.14e-05	0.00122	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL4—rheumatoid arthritis	7.12e-05	0.00122	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.05e-05	0.00121	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.05e-05	0.00121	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IFNG—rheumatoid arthritis	6.97e-05	0.00119	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—HLA-B—rheumatoid arthritis	6.97e-05	0.00119	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—LEP—rheumatoid arthritis	6.96e-05	0.00119	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2RB—rheumatoid arthritis	6.86e-05	0.00117	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—FASLG—rheumatoid arthritis	6.81e-05	0.00116	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	6.79e-05	0.00116	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	6.78e-05	0.00116	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—CCL2—rheumatoid arthritis	6.67e-05	0.00114	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—KIF5A—rheumatoid arthritis	6.67e-05	0.00114	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—FAS—rheumatoid arthritis	6.56e-05	0.00112	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL2RA—rheumatoid arthritis	6.53e-05	0.00112	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—rheumatoid arthritis	6.48e-05	0.00111	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—C3—rheumatoid arthritis	6.47e-05	0.00111	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—HLA-A—rheumatoid arthritis	6.45e-05	0.0011	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—CRP—rheumatoid arthritis	6.45e-05	0.0011	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—FN1—rheumatoid arthritis	6.42e-05	0.0011	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RAD51B—rheumatoid arthritis	6.39e-05	0.00109	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL1B—rheumatoid arthritis	6.22e-05	0.00106	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—rheumatoid arthritis	6.12e-05	0.00105	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—POMC—rheumatoid arthritis	6.05e-05	0.00104	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	5.95e-05	0.00102	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.94e-05	0.00102	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	5.92e-05	0.00101	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	5.9e-05	0.00101	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ENO1—rheumatoid arthritis	5.82e-05	0.000996	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—NFKB1—rheumatoid arthritis	5.8e-05	0.000993	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	5.77e-05	0.000987	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IFNG—rheumatoid arthritis	5.67e-05	0.000971	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	5.6e-05	0.000958	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CCR5—rheumatoid arthritis	5.54e-05	0.000947	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CCR5—rheumatoid arthritis	5.54e-05	0.000947	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	5.46e-05	0.000934	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CD80—rheumatoid arthritis	5.45e-05	0.000932	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CAT—rheumatoid arthritis	5.43e-05	0.000929	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CAT—rheumatoid arthritis	5.43e-05	0.000929	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MTHFR—rheumatoid arthritis	5.41e-05	0.000925	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MTHFR—rheumatoid arthritis	5.41e-05	0.000925	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—HLA-A—rheumatoid arthritis	5.4e-05	0.000923	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—HLA-A—rheumatoid arthritis	5.4e-05	0.000923	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	5.3e-05	0.000907	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PDE2A—rheumatoid arthritis	5.3e-05	0.000906	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL1B—rheumatoid arthritis	5.06e-05	0.000866	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL2—rheumatoid arthritis	5.04e-05	0.000863	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TIMP1—rheumatoid arthritis	5.02e-05	0.000859	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.95e-05	0.000847	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.95e-05	0.000847	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PLEK—rheumatoid arthritis	4.85e-05	0.000829	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLD4—rheumatoid arthritis	4.77e-05	0.000815	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6ST—rheumatoid arthritis	4.73e-05	0.000809	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6ST—rheumatoid arthritis	4.73e-05	0.000809	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—NFKB1—rheumatoid arthritis	4.72e-05	0.000808	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	4.72e-05	0.000806	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	4.71e-05	0.000805	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS2—rheumatoid arthritis	4.69e-05	0.000803	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS2—rheumatoid arthritis	4.69e-05	0.000803	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ACAN—rheumatoid arthritis	4.6e-05	0.000787	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.6e-05	0.000787	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CD80—rheumatoid arthritis	4.55e-05	0.000779	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CD80—rheumatoid arthritis	4.55e-05	0.000779	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MTHFR—rheumatoid arthritis	4.53e-05	0.000775	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MTHFR—rheumatoid arthritis	4.53e-05	0.000775	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—RASGRP1—rheumatoid arthritis	4.52e-05	0.000773	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—TNF—rheumatoid arthritis	4.51e-05	0.000772	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	4.51e-05	0.000771	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SYK—rheumatoid arthritis	4.5e-05	0.00077	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PRKCQ—rheumatoid arthritis	4.42e-05	0.000756	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC25A12—rheumatoid arthritis	4.33e-05	0.00074	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—PTGS2—rheumatoid arthritis	4.32e-05	0.000739	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IFNG—rheumatoid arthritis	4.31e-05	0.000737	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	4.27e-05	0.000731	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6R—rheumatoid arthritis	4.22e-05	0.000722	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6R—rheumatoid arthritis	4.22e-05	0.000722	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGES—rheumatoid arthritis	4.21e-05	0.00072	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GC—rheumatoid arthritis	4.21e-05	0.00072	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CAT—rheumatoid arthritis	4.19e-05	0.000717	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	4.12e-05	0.000705	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	4.03e-05	0.00069	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	4.02e-05	0.000688	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CXCL8—rheumatoid arthritis	4e-05	0.000685	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—TGFB1—rheumatoid arthritis	3.98e-05	0.000681	CbGpPWpGaD
Canagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	3.97e-05	0.00068	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLB1—rheumatoid arthritis	3.91e-05	0.000669	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—TGFB1—rheumatoid arthritis	3.88e-05	0.000664	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TYK2—rheumatoid arthritis	3.84e-05	0.000658	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TYK2—rheumatoid arthritis	3.84e-05	0.000658	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL1B—rheumatoid arthritis	3.84e-05	0.000657	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	3.84e-05	0.000656	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL2—rheumatoid arthritis	3.83e-05	0.000655	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS3—rheumatoid arthritis	3.77e-05	0.000645	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS3—rheumatoid arthritis	3.77e-05	0.000645	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PTK2—rheumatoid arthritis	3.76e-05	0.000643	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	3.76e-05	0.000642	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	3.75e-05	0.000642	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FADS2—rheumatoid arthritis	3.74e-05	0.00064	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—VEGFA—rheumatoid arthritis	3.67e-05	0.000628	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—rheumatoid arthritis	3.67e-05	0.000628	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—rheumatoid arthritis	3.64e-05	0.000623	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—CSF2—rheumatoid arthritis	3.63e-05	0.000621	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—POMC—rheumatoid arthritis	3.62e-05	0.00062	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—POMC—rheumatoid arthritis	3.62e-05	0.00062	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2RB—rheumatoid arthritis	3.53e-05	0.000605	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—rheumatoid arthritis	3.5e-05	0.000599	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MTHFR—rheumatoid arthritis	3.5e-05	0.000598	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CD4—rheumatoid arthritis	3.48e-05	0.000595	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CD4—rheumatoid arthritis	3.48e-05	0.000595	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—rheumatoid arthritis	3.45e-05	0.00059	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—rheumatoid arthritis	3.45e-05	0.00059	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MED1—rheumatoid arthritis	3.43e-05	0.000587	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SELE—rheumatoid arthritis	3.41e-05	0.000584	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—TGFB1—rheumatoid arthritis	3.37e-05	0.000577	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	3.36e-05	0.000575	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	3.36e-05	0.000575	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ALB—rheumatoid arthritis	3.3e-05	0.000565	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ALB—rheumatoid arthritis	3.3e-05	0.000565	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FADS2—rheumatoid arthritis	3.28e-05	0.000561	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	3.27e-05	0.00056	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—VEGFA—rheumatoid arthritis	3.25e-05	0.000556	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	3.24e-05	0.000554	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—rheumatoid arthritis	3.24e-05	0.000554	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	3.22e-05	0.000551	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—rheumatoid arthritis	3.21e-05	0.00055	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—ITGAM—rheumatoid arthritis	3.21e-05	0.000549	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—B3GNT2—rheumatoid arthritis	3.19e-05	0.000546	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ACP5—rheumatoid arthritis	3.19e-05	0.000546	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NOS3—rheumatoid arthritis	3.16e-05	0.000541	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NOS3—rheumatoid arthritis	3.16e-05	0.000541	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.11e-05	0.000532	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SH2B3—rheumatoid arthritis	3.04e-05	0.00052	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TGFB1—rheumatoid arthritis	2.98e-05	0.000511	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—rheumatoid arthritis	2.96e-05	0.000507	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	2.93e-05	0.000501	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.92e-05	0.000499	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—rheumatoid arthritis	2.89e-05	0.000494	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—rheumatoid arthritis	2.89e-05	0.000494	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—BGN—rheumatoid arthritis	2.87e-05	0.000491	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	2.85e-05	0.000487	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—POMC—rheumatoid arthritis	2.8e-05	0.000479	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—rheumatoid arthritis	2.79e-05	0.000477	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—GATA3—rheumatoid arthritis	2.73e-05	0.000467	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALOX5—rheumatoid arthritis	2.64e-05	0.000452	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TIMP1—rheumatoid arthritis	2.59e-05	0.000443	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	2.57e-05	0.000439	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—rheumatoid arthritis	2.55e-05	0.000436	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLD4—rheumatoid arthritis	2.5e-05	0.000427	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFB1—rheumatoid arthritis	2.5e-05	0.000427	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFB1—rheumatoid arthritis	2.5e-05	0.000427	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NOS3—rheumatoid arthritis	2.44e-05	0.000417	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ACAN—rheumatoid arthritis	2.41e-05	0.000412	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—rheumatoid arthritis	2.35e-05	0.000403	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RASGRP1—rheumatoid arthritis	2.33e-05	0.000398	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.33e-05	0.000398	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SYK—rheumatoid arthritis	2.32e-05	0.000397	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PRKCQ—rheumatoid arthritis	2.28e-05	0.00039	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC25A12—rheumatoid arthritis	2.27e-05	0.000388	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—rheumatoid arthritis	2.23e-05	0.000382	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGES—rheumatoid arthritis	2.2e-05	0.000377	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GC—rheumatoid arthritis	2.2e-05	0.000377	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLD4—rheumatoid arthritis	2.19e-05	0.000374	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ENO1—rheumatoid arthritis	2.16e-05	0.000369	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.12e-05	0.000363	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ACAN—rheumatoid arthritis	2.11e-05	0.000361	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLB1—rheumatoid arthritis	2.05e-05	0.000351	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	2.04e-05	0.000348	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	2.02e-05	0.000345	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.99e-05	0.00034	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.97e-05	0.000336	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PTK2—rheumatoid arthritis	1.94e-05	0.000331	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GC—rheumatoid arthritis	1.93e-05	0.00033	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1.93e-05	0.00033	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	1.92e-05	0.000328	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—rheumatoid arthritis	1.88e-05	0.000322	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—rheumatoid arthritis	1.88e-05	0.000322	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CSF2—rheumatoid arthritis	1.87e-05	0.00032	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.85e-05	0.000317	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MED1—rheumatoid arthritis	1.8e-05	0.000307	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.8e-05	0.000307	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.77e-05	0.000302	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.74e-05	0.000297	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.71e-05	0.000293	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2RA—rheumatoid arthritis	1.69e-05	0.000288	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—B3GNT2—rheumatoid arthritis	1.67e-05	0.000286	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ACP5—rheumatoid arthritis	1.67e-05	0.000286	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	1.63e-05	0.000279	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MMP1—rheumatoid arthritis	1.61e-05	0.000275	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.6e-05	0.000274	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MED1—rheumatoid arthritis	1.57e-05	0.000269	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAT—rheumatoid arthritis	1.55e-05	0.000265	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BGN—rheumatoid arthritis	1.5e-05	0.000257	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	1.5e-05	0.000256	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.47e-05	0.000252	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—FN1—rheumatoid arthritis	1.47e-05	0.000251	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	1.46e-05	0.00025	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ACP5—rheumatoid arthritis	1.46e-05	0.00025	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS2—rheumatoid arthritis	1.45e-05	0.000248	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ALOX5—rheumatoid arthritis	1.38e-05	0.000237	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.38e-05	0.000235	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.35e-05	0.00023	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BGN—rheumatoid arthritis	1.32e-05	0.000225	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.3e-05	0.000223	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—rheumatoid arthritis	1.29e-05	0.000221	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.22e-05	0.000209	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.22e-05	0.000208	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	1.21e-05	0.000207	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.21e-05	0.000207	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.19e-05	0.000204	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.19e-05	0.000204	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—rheumatoid arthritis	1.17e-05	0.000199	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ENO1—rheumatoid arthritis	1.13e-05	0.000193	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.11e-05	0.000189	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—POMC—rheumatoid arthritis	1.04e-05	0.000177	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ENO1—rheumatoid arthritis	9.89e-06	0.000169	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2—rheumatoid arthritis	9.89e-06	0.000169	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	9.71e-06	0.000166	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MED1—rheumatoid arthritis	9.7e-06	0.000166	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—rheumatoid arthritis	9.44e-06	0.000161	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	9.25e-06	0.000158	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—rheumatoid arthritis	9.03e-06	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	9.02e-06	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	9.02e-06	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—rheumatoid arthritis	8.4e-06	0.000144	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—rheumatoid arthritis	8.26e-06	0.000141	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAT—rheumatoid arthritis	8.12e-06	0.000139	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BGN—rheumatoid arthritis	8.12e-06	0.000139	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—rheumatoid arthritis	7.71e-06	0.000132	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	7.47e-06	0.000128	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAT—rheumatoid arthritis	7.12e-06	0.000122	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—rheumatoid arthritis	6.78e-06	0.000116	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—rheumatoid arthritis	6.35e-06	0.000109	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	6.09e-06	0.000104	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	5.94e-06	0.000102	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—POMC—rheumatoid arthritis	5.42e-06	9.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—POMC—rheumatoid arthritis	4.75e-06	8.12e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—rheumatoid arthritis	4.73e-06	8.09e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.38e-06	7.5e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—rheumatoid arthritis	4.33e-06	7.41e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—rheumatoid arthritis	4.32e-06	7.4e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—rheumatoid arthritis	4.14e-06	7.09e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.79e-06	6.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.66e-06	6.26e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.93e-06	5.01e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.67e-06	4.56e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.55e-06	4.37e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.33e-06	3.99e-05	CbGpPWpGaD
